Obesity drug industry could be worth $200 billion within the decade, says Barclays, as market valuations grow

  • 📰 CNBC
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 72%

Canada News News

Canada Canada Latest News,Canada Canada Headlines

The burgeoning weight-loss drug industry could be worth as much as $200 billion within the next decade, according to Barclays bank.

Their dramatic results have been pitched as a "miracle" fix to weight issues, with Hollywood stars and social media influencers among those touting their benefits.

Others, meanwhile, have questioned whether the drugs can successfully tackle the longer-term health issues facing those with obesity.However, Field said that a forthcoming study, due this summer, could go further in uncovering the cardiovascular benefits of such drugs and therefore their wider-reaching applications.

Weight-loss drugs have become a hot topic as public heath authorities and pharmaceutical companies seek to find solutions to the growing global obesity epidemic."So we all think this should work, but it's a very, very important event so there's certainly a lot of anxiety going into this [study]," she said.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in CA

Canada Canada Latest News, Canada Canada Headlines